News
The FDA has escalated Alma Pak International LLC's organic blueberry recall to a Class I, the most severe classification, ...
A recall was announced after bacteria were found that could cause serious adverse health consequences or death.
Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...
A new FDA alert has classified and updated a recent blueberry recall as a Class I health risk, the agency’s most serious ...
The FDA has granted accelerated approval to linvoseltamab-gcpt (Lynozyfic) for the treatment of adult patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results